Axiom Raises Seed Funding for Longevity Tech

South Korean startup Axiom has secured initial funding from prominent venture capital firms Kakao Ventures and Futureplay to advance its mission of making healthspan extension accessible. The company, which operates under the vision of \"Sustainable Longevity for All,\" aims to dismantle the financial, informational, and technological hurdles that currently limit widespread adoption of longevity practices.

Axiom's strategic approach involves a self-sustaining model where revenue generated from accessible brands and evidence-based media is channeled back into biotechnology commercialization. A significant commitment of 10% of its revenue over the next three years is earmarked for research and development, underscoring a deep dedication to technological advancement in the longevity space. This focus on reinvestment in R&D positions Axiom to potentially disrupt a market often characterized by high-cost, exclusive solutions.

The company's inaugural brand, Roadic, is set to launch in September, featuring the Roadic Air Booster. This innovative home recovery device utilizes proprietary cold-plasma technology, licensed for in-house development. Unlike conventional beauty devices that rely on physical or thermal methods, the Air Booster employs a controlled generation of reactive oxygen species (ROS) to stimulate cellular repair and regeneration, enhancing skin's natural healing processes. This technological differentiation is further complemented by three specialized skincare formulations designed to work synergistically with the device.

Roadic is redefining daily wellness routines by framing a ten-minute post-sauna skincare regimen as a "skin recovery ritual," integrating seamlessly into modern lifestyles. Axiom's operational strategy emphasizes lean cost management from inception, with the team identifying as an AI-native organization. They leverage AI for rapid marketing experiment cycles and optimize ad spend based on measurable customer engagement, aiming for profitability within the first year of operation. Future plans include evolving into a personalized longevity data platform, capitalizing on accumulated customer insights.

The founding team brings a wealth of experience in scaling consumer brands, possessing hands-on expertise across product development, marketing, distribution, and financial management. This operational prowess, combined with Axiom's medical-science R&D capabilities in skin measurement and biomarker research, creates a unique synergy of market agility and technological depth. Investors Kakao Ventures and Futureplay highlighted this blend of rapid brand scaling and technological focus as a key differentiator.

Hyewon Ahn, principal at Kakao Ventures, commented that Axiom's team possesses the experience to scale brands rapidly while maintaining a strong technological obsession, predicting they will offer distinct value in a market often driven by marketing claims. Subin Lee, senior associate at Futureplay, added that as beauty evolves into longevity, technology will become foundational in a crowded market. They see the Roadic Air Booster as a strong catalyst for a cycle where brand performance fuels further tech commercialization and efficacy builds consumer trust.

This investment aligns with a broader trend in the South Korean beauty and wellness sector, where startups are increasingly merging technological innovation with robust brand execution. Recent funding rounds for companies like Praun and 6Pence underscore the sector's momentum towards data-driven, tech-enabled differentiation in the global market.